Robert Phelan Sells 2,186 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Key Points

• CFO Robert Phelan sold 2,186 Adtalem Global Education shares at an average price of $135.15, for proceeds of approximately $295,438. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, leaving him with 48,306 shares.
• Adtalem reported quarterly EPS of $2.09, beating analyst expectations of $1.90, on revenue of $501.38 million. The company issued fiscal 2027 EPS guidance of $8.90–$9.15.
• CVSA shares recently traded at $125.98, while analysts maintain a “Moderate Buy” consensus with an average price target of $155; the stock has a 52-week range of $86.97 to $156.26.

Adtalem Global Education Inc. (NYSE:CVSA - Get Free Report) CFO Robert Phelan sold 2,186 shares of the stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $135.15, for a total value of $295,437.90. Following the sale, the chief financial officer owned 48,306 shares of the company's stock, valued at approximately $6,528,555.90. The trade was a 4.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

Shares of NYSE:CVSA traded down $2.73 during midday trading on Tuesday, reaching $125.98. The company's stock had a trading volume of 329,097 shares, compared to its average volume of 372,013. The firm has a market capitalization of $4.29 billion, a price-to-earnings ratio of 17.89, a price-to-earnings-growth ratio of 1.05 and a beta of 0.62. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.45. The stock has a 50 day moving average of $124.82. Adtalem Global Education Inc. has a fifty-two week low of $86.97 and a fifty-two week high of $156.26.

Adtalem Global Education (NYSE:CVSA - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $2.09 EPS for the quarter, beating the consensus estimate of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The company had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, research analysts anticipate that Adtalem Global Education Inc. will post 8.95 earnings per share for the current year.

Analyst Ratings Changes

CVSA has been the topic of a number of research reports. Barrington Research reiterated an "outperform" rating and set a $170.00 target price on shares of Adtalem Global Education in a research report on Monday, June 8th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Wall Street Zen upgraded shares of Adtalem Global Education from a "hold" rating to a "buy" rating in a report on Saturday. Finally, Truist Financial increased their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Monday, May 11th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, Adtalem Global Education currently has an average rating of "Moderate Buy" and an average price target of $155.00.

About Adtalem Global Education

Adtalem Global Education NYSE: CVSA is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source